News

Ultragenyx: 'Hold' The Best Strategy As Stock Tanks On Bone Disease Study Miss
Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...
Mereo BioPharma: Buy Rating Despite No Early Study Completion Of Setrusumab For OI
Mereo BioPharma Group plc's ORBIT study for setrusumab in osteogenesis imperfecta moves to final analysis by 2025. Click for ...
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
Data from Orbit and Cosmic studies expected around the end of the yearNOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- ...
Fierce Biotech5d
Lack of early win for Ultragenyx, Mereo’s bone disorder med dents stock, but analysts keep faith
Analysts are keeping the faith in Ultragenyx’s brittle bone disease medicines despite the monoclonal antibody failing to score an early outright win in an ongoing phase 3 trail. | Analysts are keeping ...
The Week6d
Beyond the orbit: Shubhanshu Shukla’s final frontier of discovery on the ISS
As Axiom Mission 4 comes to a close, the International Space Station serves Group Captain Shubhanshu Shukla and the rest of ...
Pharmabiz4d
Ultragenyx, Mereo BioPharma announce UX143 phase 3 Orbit study for osteogenesis imperfecta progressing to final analysis
Novato, California Friday, July 11, 2025, 18:00 Hrs [IST] ...
Ultragenyx Pharmaceutical Inc.: Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase ...
NewsX12d
Chicken Legs, Sleep Disturbances And Weak Bones: How Astronauts Fight Microgravity, Radiation and Time In Space
Space challenges the human body weakening muscles, disturbing sleep, and stressing the mind. Astronauts like Sunita Williams ...
Medpage Today on MSN17d
Sports-Related Orbital Fractures a Major Cause of Facial Trauma in Young Males
The highest frequency of sports-related orbital fractures occurred in males (79%) ages 10 to 19 years. The sports most commonly associated with orbital fractures were baseball (28.6%) and bicycling ...
Investor's Business Daily on MSN5d
Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease
Ultragenyx and Mereo stocks crashed Thursday after their treatment for brittle bone disease missed its mark in a second ...
Asianet Newsable on MSN5d
Ultragenyx, Mereo Sink After Hours As Bone Drug Trial Continues Without Early Stop; Retail Traders Feel Selloff Is Overdone
Some users suggested that the market was overreacting to the update from Mereo BioPharma and Ultragenyx, with one describing ...
The Pharma Letter4d
Ultragenyx and Mereo shares plunge as brittle bone drug trial stays on course
Shares in US biotech Ultragenyx Pharmaceutical (Nasdaq: RARE) and its UK-based partner Mereo BioPharma (Nasdaq: MREO) tumbled ...